Ligand Pharmaceuticals News

8-K: Ligand Reports Second Quarter 2024 Financial Results

Aug 6 16:16 ET

8-K: Current report

Aug 2 17:21 ET

8-K: Current report

Jul 17 17:12 ET

8-K: Current report

Jul 10 16:05 ET

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jul 9 16:56 ET

8-K: Current report

Jul 8 07:42 ET

8-K: Current report

Jun 27 09:13 ET

8-K: Current report

Jun 18 17:19 ET

8-K: Current report

Jun 17 16:06 ET

DEFA14A: Others

Jun 3 16:07 ET

8-K: Current report

May 30 16:08 ET

DEFA14A: Others

May 9 17:10 ET

8-K: Ligand Reports First Quarter 2024 Financial Results

May 7 16:07 ET

8-K: Current report

May 7 07:39 ET

DEFA14A: Others

Apr 25 14:44 ET

DEF 14A: Definitive information statements

Apr 25 14:44 ET

8-K: Current report

Apr 19 16:11 ET

Ligand Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 1 16:12 ET

Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27 07:25 ET

Ligand Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET